RHYTHM PHARMACEUTICALS INC (RYTM) Stock Cash Flow
NASDAQ:RYTM - Nasdaq - US76243J1051 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -258.94M | -184.68M | -181.12M | -69.61M | -134.00M | |||
| Depreciation Amortization | 1.60M | 1.76M | 1.67M | 1.16M | 690.00K | |||
| Change In Working Capital | 9.27M | 4.81M | -19.72M | 1.90M | -5.90M | |||
| Other non cash items | 123.66M | 41.96M | 25.74M | -79.45M | 17.22M | |||
| OPERATING CASH FLOW | -124.42M | -136.16M | -173.43M | -146.00M | -121.98M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -47.00K | -280.00K | -430.00K | -210.00K | |||
| Other Investing Activity | -46.69M | -5.62M | 28.31M | -61.73M | 158.75M | |||
| INVESTING CASH FLOW | -46.69M | -5.67M | 28.03M | -62.16M | 158.53M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -11.67M | 16.97M | 72.34M | N/A | N/A | |||
| Stock Issued/Repurchased | 158.10M | 57.40M | 141.49M | 166.48M | 2.01M | |||
| FINANCING CASH FLOW | 155.33M | 74.37M | 213.83M | 166.48M | 2.01M | |||
| Exchange Rate Effect | -1.17M | -142.00K | N/A | N/A | N/A | |||
| CHANGE IN CASH | -16.94M | -67.60M | 68.43M | -41.68M | 38.56M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -124.42M | -136.16M | -173.43M | -146.00M | -121.98M | |||
| Capital Expenditure | N/A | -47.00K | -280.00K | -430.00K | -210.00K | |||
| FREE CASH FLOW | -124.42M | -136.20M | -173.71M | -146.43M | -122.19M | |||
All data in USD